Pfizer acquires Redvax for its potential herpes vaccine

January 5, 2015 1:06 PM

3 0

Pfizer acquires Redvax for its potential herpes vaccine

Pfizer Inc. has acquired a controlling interest in privately held Redvax GmbH, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.

Pfizer PFE, +0.58% will also receive the intellectual property and technology platform related to a second, undisclosed vaccine program.

Read more

To category page

Loading...